<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1364" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1364/" /><meta name="ncbi_pagename" content="GATA1-Related X-Linked Cytopenia - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>GATA1-Related X-Linked Cytopenia - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="GATA1-Related X-Linked Cytopenia" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2017/05/11" /><meta name="citation_author" content="Stella T Chou" /><meta name="citation_author" content="Melissa A Kacena" /><meta name="citation_author" content="Mitchell J Weiss" /><meta name="citation_author" content="Wendy H Raskind" /><meta name="citation_pmid" content="20301538" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1364/" /><meta name="citation_keywords" content="Erythroid transcription factor" /><meta name="citation_keywords" content="GATA1" /><meta name="citation_keywords" content="GATA1-Related X-Linked Cytopenia" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="GATA1-Related X-Linked Cytopenia" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Stella T Chou" /><meta name="DC.Contributor" content="Melissa A Kacena" /><meta name="DC.Contributor" content="Mitchell J Weiss" /><meta name="DC.Contributor" content="Wendy H Raskind" /><meta name="DC.Date" content="2017/05/11" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1364/" /><meta name="description" content="GATA1-related cytopenia is characterized by thrombocytopenia and/or anemia ranging from mild to severe. One or more of the following may also be present: platelet dysfunction, mild β-thalassemia, neutropenia, and congenital erythropoietic porphyria (CEP) in males. Thrombocytopenia typically presents in infancy as a bleeding disorder with easy bruising and mucosal bleeding (e.g., epistaxis). Anemia ranges from minimal (mild dyserythropoiesis) to severe (hydrops fetalis requiring in utero transfusion). At the extreme end of the clinical spectrum, severe hemorrhage and/or erythrocyte transfusion dependence are life long; at the milder end, anemia and the risk for bleeding may decrease spontaneously with age. Heterozygous females may have mild to moderate symptoms such as menorrhagia." /><meta name="og:title" content="GATA1-Related X-Linked Cytopenia" /><meta name="og:type" content="book" /><meta name="og:description" content="GATA1-related cytopenia is characterized by thrombocytopenia and/or anemia ranging from mild to severe. One or more of the following may also be present: platelet dysfunction, mild β-thalassemia, neutropenia, and congenital erythropoietic porphyria (CEP) in males. Thrombocytopenia typically presents in infancy as a bleeding disorder with easy bruising and mucosal bleeding (e.g., epistaxis). Anemia ranges from minimal (mild dyserythropoiesis) to severe (hydrops fetalis requiring in utero transfusion). At the extreme end of the clinical spectrum, severe hemorrhage and/or erythrocyte transfusion dependence are life long; at the milder end, anemia and the risk for bleeding may decrease spontaneously with age. Heterozygous females may have mild to moderate symptoms such as menorrhagia." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1364/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/gata1/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1364/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CDE4FE0402651000000000711026C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1364_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1364_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cmt2d/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cmt-4a/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1364_"><span class="title" itemprop="name"><i>GATA1</i>-Related X-Linked Cytopenia</span></h1><p class="contrib-group"><span itemprop="author">Stella T Chou</span>, MD, <span itemprop="author">Melissa A Kacena</span>, PhD, <span itemprop="author">Mitchell J Weiss</span>, MD, PhD, and <span itemprop="author">Wendy H Raskind</span>, MD, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1364_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1364_ai__"><div class="contrib half_rhythm"><span itemprop="author">Stella T Chou</span>, MD<div class="affiliation small">Assistant Professor, Pediatrics<br />University of Pennsylvania School of Medicine<br />Division of Hematology<br />The Children's Hospital of Philadelphia<br />Philadelphia, Pennsylvania<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.pohc.liame@suohc" class="oemail">ude.pohc.liame@suohc</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Melissa A Kacena</span>, PhD<div class="affiliation small">Associate Professor, Department of Orthopaedic Surgery<br />Indiana University School of Medicine<br />Indianapolis, Indiana<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.iupui@anecakm" class="oemail">ude.iupui@anecakm</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Mitchell J Weiss</span>, MD, PhD<div class="affiliation small">Professor, Pediatrics<br />Department of Hematology<br />St Jude Children's Research Hospital<br />Memphis, Tennessee<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="gro.edujts@ssiew.hctim" class="oemail">gro.edujts@ssiew.hctim</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Wendy H Raskind</span>, MD, PhD<div class="affiliation small">Professor, Departments of Medicine and Psychiatry and Behavioral Sciences<br />University of Washington Medical Center<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@nurydnew" class="oemail">ude.wu@nurydnew</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 22, 2006</span>; Last Update: <span itemprop="dateModified">May 11, 2017</span>.</p><p><em>Estimated reading time: 26 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="gata1.Summary" itemprop="description"><h2 id="_gata1_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p><i>GATA1</i>-related cytopenia is characterized by thrombocytopenia and/or anemia ranging from mild to severe. One or more of the following may also be present: platelet dysfunction, mild &#x003b2;-thalassemia, neutropenia, and <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> erythropoietic porphyria (CEP) in males. Thrombocytopenia typically presents in infancy as a bleeding disorder with easy bruising and mucosal bleeding (e.g., epistaxis). Anemia ranges from minimal (mild dyserythropoiesis) to severe (hydrops fetalis requiring in utero transfusion). At the extreme end of the clinical spectrum, severe hemorrhage and/or erythrocyte transfusion dependence are life long; at the milder end, anemia and the risk for bleeding may decrease spontaneously with age. Heterozygous females may have mild to moderate symptoms such as menorrhagia.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>Diagnostic laboratory findings usually include macrothrombocytopenia (low number of platelets that are larger than normal) and/or anemia with red cell indices that may be micro-, normo- or macrocytic. Defects in platelet aggregation in response to agonists may be seen. In some cases electron microscopy reveals reduced numbers of platelet alpha granules and dysplastic features in platelets and megakaryocytes.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Platelet transfusions for moderate to severe epistaxis, gingival bleeding, or gastrointestinal bleeding; no specific treatment for mild symptoms (easy bruisability); erythrocyte transfusions when anemia is symptomatic (fatigue, tachycardia).</p><p><i>Prevention of primary manifestations</i>: For severe cases, bone marrow transplantation (BMT) can be curative.</p><p><i>Surveillance</i>: Monitoring complete blood counts (with frequency depending on disease severity) to inform supportive care; monitoring those undergoing repeated erythrocyte transfusions for iron overload.</p><p><i>Agents/circumstances to avoid</i>: Those with thrombocytopenia should avoid antiplatelet agents including aspirin and nonsteroidal anti-inflammatory agents (e.g., ibuprofen). Those with thrombocytopenia and/or platelet aggregation defects should avoid contact sports or activities with a high risk of trauma.</p><p><i>Evaluation of relatives at risk</i>: If a <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the family, complete blood counts and <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of at-risk relatives can be offered. At-risk relatives who choose not to have molecular genetic testing should have complete blood counts to evaluate for thrombocytopenia, anemia, or neutropenia.</p></div><div><h4 class="inline">Genetic counseling.</h4><p><i>GATA1</i>-related cytopenia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. If the mother of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male has a <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%. Affected males pass the pathogenic variant to all of their daughters and none of their sons. Testing for at-risk family members and prenatal testing for pregnancies at increased risk are possible once the pathogenic variant has been identified in the family.</p></div></div><div id="gata1.Diagnosis"><h2 id="_gata1_Diagnosis_">Diagnosis</h2><div id="gata1.Suggestive_Findings"><h3>Suggestive Findings</h3><p><i>GATA1</i>-related cytopenia <b>should be suspected</b> in an individual with the following:</p><ul><li class="half_rhythm"><div>Thrombocytopenia and/or anemia ranging from mild to severe (including fetal hydrops)</div></li><li class="half_rhythm"><div>One or more of the following:</div><ul><li class="half_rhythm"><div>Platelet dysfunction</div></li><li class="half_rhythm"><div>Mild &#x003b2;-thalassemia</div></li><li class="half_rhythm"><div>Neutropenia</div></li><li class="half_rhythm"><div><a href="/books/n/gene/cep/">Congenital erythropoietic porphyria</a> (CEP)</div></li></ul></li><li class="half_rhythm"><div>Family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance</div></li><li class="half_rhythm"><div>No evidence of <a href="/books/n/gene/was/">Wiskott-Aldrich syndrome</a> (WAS), an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder of microthrombocytopenia that can present with or without immunodeficiency</div></li></ul><p>Note: 1) Initial testing should include complete blood count, examination of the blood smear, and bone marrow aspirate and biopsy to confirm that cytopenia results from ineffective hematopoiesis rather than peripheral destruction or sequestration. 2) Hematologic findings in <i>GATA1</i>-related cytopenia are variable and usually nonspecific (i.e., seen in numerous conditions and thus by themselves not indicative of a specific diagnosis). 3) Affected individuals are typically male; females will usually present with milder findings.</p></div><div id="gata1.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of <i>GATA1</i>-related cytopenia <b>is established</b> in a male proband with cytopenia resulting from ineffective hematopoiesis by identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GATA1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1364/table/gata1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figgata1Tmoleculargenetictestingusedi" rid-ob="figobgata1Tmoleculargenetictestingusedi">Table 1</a>).</p><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of <i>GATA1</i>-related cytopenia <b>may be established</b> in a female proband with hematopoietic cytopenias by identification of a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GATA1</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (<a class="figpopup" href="/books/NBK1364/table/gata1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figgata1Tmoleculargenetictestingusedi" rid-ob="figobgata1Tmoleculargenetictestingusedi">Table 1</a>). A pattern of skewed X-inactivation would support the diagnosis. Note: This disorder is not usually first diagnosed in a family via a female proband.</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of <i>GATA1</i> is performed. Although no <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-gene deletions or duplications have been reported as a cause of <i>GATA1</i>-related cytopenias, some laboratories offer gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> if a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not found.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>GATA1</i> and other genes of interest (see <a href="#gata1.Differential_Diagnosis">Differential Diagnosis</a>) may be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or genes that results in a similar clinical presentation). For an introduction to comprehensive genomic testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="gata1.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in <i>GATA1</i>-Related Cytopenia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1364/table/gata1.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gata1.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>GATA1</i></td><td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">22/22&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>6</sup></td><td headers="hd_h_gata1.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gata1.TF.1.1"><p class="no_margin">See <a href="/books/NBK1364/#gata1.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="gata1.TF.1.2"><p class="no_margin">See <a href="#gata1.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="gata1.TF.1.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="gata1.TF.1.4"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation requires additional testing by gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>5. </dt><dd><div id="gata1.TF.1.5"><p class="no_margin"><a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al [2000]</a>, <a class="bk_pop" href="#gata1.REF.mehaffey.2001.2681">Mehaffey et al [2001]</a>, <a class="bk_pop" href="#gata1.REF.freson.2002.147">Freson et al [2002]</a>, <a class="bk_pop" href="#gata1.REF.yu.2002.2040">Yu et al [2002]</a>, <a class="bk_pop" href="#gata1.REF.balduini.2004.129">Balduini et al [2004]</a>, <a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al [2005]</a>, <a class="bk_pop" href="#gata1.REF.hughan.2005.4369">Hughan et al [2005]</a>, <a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al [2006]</a>, <a class="bk_pop" href="#gata1.REF.phillips.2007.2618">Phillips et al [2007]</a>, <a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al [2012]</a>, <a class="bk_pop" href="#gata1.REF.klar.2014.949">Klar et al [2014]</a>, <a class="bk_pop" href="#gata1.REF.parrella.2014.1319">Parrella et al [2014]</a>, <a class="bk_pop" href="#gata1.REF._str_m.2015.e44">&#x000c5;str&#x000f6;m et al [2015]</a>, <a class="bk_pop" href="#gata1.REF.di_pierro.2015.491">Di Pierro et al [2015]</a>, <a class="bk_pop" href="#gata1.REF.zucker.2016.917">Zucker et al [2016]</a></p></div></dd><dt>6. </dt><dd><div id="gata1.TF.1.6"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>7. </dt><dd><div id="gata1.TF.1.7"><p class="no_margin">No data on detection rate of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> are available.</p></div></dd></dl></div></div></div></div></div><div id="gata1.Clinical_Characteristics"><h2 id="_gata1_Clinical_Characteristics_">Clinical Characteristics</h2><div id="gata1.Clinical_Description"><h3>Clinical Description</h3><p>Individuals with <i>GATA1</i>-related cytopenia have thrombocytopenia and/or anemia.</p><p><b>Males</b></p><ul><li class="half_rhythm"><div>Males typically present in infancy with a bleeding disorder:</div><ul><li class="half_rhythm"><div>Affected individuals have easy bruising and mucosal bleeding (e.g., epistaxis).</div></li><li class="half_rhythm"><div>Physical examination may reveal petechiae, ecchymoses, or splenomegaly.</div></li><li class="half_rhythm"><div>Excessive hemorrhage and/or bruising can occur either spontaneously or after trauma or surgery.</div></li></ul></li><li class="half_rhythm"><div>Anemia, the other major clinical problem in males with this disorder, ranges from minimal with only mild dyserythropoiesis [<a class="bk_pop" href="#gata1.REF.freson.2001.85">Freson et al 2001</a>] to severe hydrops fetalis requiring in utero transfusions [<a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al 2000</a>].</div><ul><li class="half_rhythm"><div>Anemia can be so severe that <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males are red blood cell transfusion dependent from birth [<a class="bk_pop" href="#gata1.REF.freson.2002.147">Freson et al 2002</a>].</div></li><li class="half_rhythm"><div>In one family, moderately severe anemia was associated with <a href="/books/n/gene/cep/">congenital erythropoietic porphyria</a> (CEP) with no pathogenic variants detected in <i>UROS</i>; an Arg216Trp <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> was identified in <i>GATA1</i> [<a class="bk_pop" href="#gata1.REF.phillips.2007.2618">Phillips et al 2007</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual also had bullous skin lesions associated with porphyria. In two additional probands with CEP, anemia and thrombocytopenia, a pathogenic variant in <i>UROS</i> or <i>SEC23B</i> was detected in addition to an Arg216Trp variant in <i>GATA1</i> [<a class="bk_pop" href="#gata1.REF.di_pierro.2015.491">Di Pierro et al 2015</a>].</div></li><li class="half_rhythm"><div>Variable mild to moderate neutropenia with macrocytic anemia and normal platelet counts has been reported in association with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulting in a truncated protein (GATA-1s; discussed in <a href="#gata1.Molecular_Genetics">Molecular Genetics</a>, <b>Pathogenic variants</b>) [<a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>, <a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>, <a class="bk_pop" href="#gata1.REF.zucker.2016.917">Zucker et al 2016</a>]; family members with severe neutropenia were predisposed to infection [<a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>].</div></li></ul></li><li class="half_rhythm"><div>Splenomegaly is commonly present in one form of <i>GATA1</i>-related disease (see <a href="#gata1.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a>). Typically, no other physical anomalies are present.</div></li></ul><p><b>Laboratory findings in males</b></p><ul><li class="half_rhythm"><div class="half_rhythm">Complete blood count showing the following:</div><ul><li class="half_rhythm"><div>Platelet counts are usually low (10-100 x 10<sup>3</sup>/&#x000b5;L), but vary considerably with specific pathogenic variants. Normal counts have also been reported (150-400 x 10<sup>3</sup>/&#x000b5;L), including individuals with a <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulting in a truncated protein (GATA-1s; see <a href="#gata1.Molecular_Genetics">Molecular Genetics</a>, <b>Pathogenic variants</b>) causing <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anemia [<a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>, <a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>]. The platelets are typically larger than normal (macrothrombocytopenia).</div></li><li class="half_rhythm"><div>Anemia (hematocrit 16%-35%; normal: 35%-45%) may be present; the severity varies with the specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Red cell indices are normochromic but may be mildly microcytic (75-79 fL) or macrocytic (101-103 fL) (normal: 80-99 fL).</div></li><li class="half_rhythm"><div>Significant persistent neutropenia (0.5-2.8 x 10<sup>3</sup>/&#x000b5;L; normal 1.9-8.0 x 10<sup>3</sup>/&#x000b5;L) was observed in one family with a specific <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>]; findings were variable in families with other <i>GATA1</i> variants [<a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>, <a class="bk_pop" href="#gata1.REF.zucker.2016.917">Zucker et al 2016</a>].</div></li></ul><div class="half_rhythm">Note: Thrombocytopenia, anemia, and neutropenia are usually defined as two standard deviations below values observed in the normal population.</div></li><li class="half_rhythm"><div class="half_rhythm">Peripheral blood smear that may show the following:</div><ul><li class="half_rhythm"><div>Some platelets that are larger and more spherical than the typical discoid morphology. Platelets may be pale, reflecting reduced granularity.</div></li><li class="half_rhythm"><div>Variation in erythrocyte size and shape and hypochromia, reflecting low hemoglobin content</div></li><li class="half_rhythm"><div>Decreased neutrophils with abnormal morphology; this rare finding was reported in one family with an unusual <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> resulting in a truncated protein (GATA-1s; discussed in <a href="#gata1.Molecular_Genetics">Molecular Genetics</a>, <b>Pathogenic variants</b>) [<a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>].</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Bone marrow biopsy that may show the following:</div><ul><li class="half_rhythm"><div>Hyper- or hypocellularity</div></li><li class="half_rhythm"><div>Increased or decreased numbers of megakaryocytes</div></li><li class="half_rhythm"><div>Small, dysplastic megakaryocytes with signs of incomplete maturation</div></li><li class="half_rhythm"><div>Dyserythropoiesis</div></li><li class="half_rhythm"><div>Hypocellularity of erythroid and granulocytic lineages</div></li><li class="half_rhythm"><div>Mild to moderate reticulin fibrosis [<a class="bk_pop" href="#gata1.REF._str_m.2015.e44">&#x000c5;str&#x000f6;m et al 2015</a>]</div></li></ul></li><li class="half_rhythm"><div class="half_rhythm">Platelet function abnormalities. Defects in platelet aggregation in response to agonists (e.g., ristocetin, adenosine diphosphate, epinephrine, or collagen) occur in some cases [<a class="bk_pop" href="#gata1.REF.thompson.1977.303">Thompson et al 1977</a>, <a class="bk_pop" href="#gata1.REF.freson.2001.85">Freson et al 2001</a>, <a class="bk_pop" href="#gata1.REF.balduini.2004.129">Balduini et al 2004</a>, <a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>]. These studies can be normal in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div class="half_rhythm">Electron microscopy. Findings in some cases include reduced numbers of platelet alpha granules and dysplastic features in megakaryocytes and platelets.</div></li><li class="half_rhythm"><div class="half_rhythm">In subtypes associated with globin chain imbalance, findings consistent with mild hemolysis, including mild reticulocytosis, elevated LDH, and low haptoglobin, may be present. In addition, HbA2 and HbF may be elevated.</div></li></ul><div id="gata1.T.terms_used_to_describe_this_diso" class="table"><div class="caption"><p>Terms Used to Describe This Disorder</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1364/table/gata1.T.terms_used_to_describe_this_diso/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gata1.T.terms_used_to_describe_this_diso_lrgtbl__"><table><thead><tr><th id="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Term</th><th id="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Definition</th></tr></thead><tbody><tr><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Thrombocytopenia</b></td><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reduced platelet count</td></tr><tr><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Macrothrombocytopenia</b></td><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thrombocytopenia w/large platelets</td></tr><tr><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dyserythropoiesis</b></td><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Impaired production &#x00026; maturation of erythrocytes (red blood cells)</td></tr><tr><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Thalassemia</b></td><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">An inherited form of anemia associated w/unbalanced globin chain synthesis</td></tr><tr><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hemoglobin</b></td><td headers="hd_h_gata1.T.terms_used_to_describe_this_diso_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">The oxygen-carrying compound of red blood cells, made up of heme, &#x003b1;-globin, &#x00026; &#x003b2;-globin. &#x003b2;-thalassemia is associated w/decreased &#x003b2;-globin synthesis in red blood cells.</td></tr></tbody></table></div></div><p><b>Findings in <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females.</b> Females may manifest platelet abnormalities [<a class="bk_pop" href="#gata1.REF.white.2007.620">White 2007</a>] and mild to moderate symptoms such as menorrhagia or easy bruising, presumably related to the proportion of relevant cells that contain the pathogenic <i>GATA1</i> variant on the active X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> [<a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al 2000</a>; <a class="bk_pop" href="#gata1.REF.raskind.2000.2262">Raskind et al 2000</a>; <a class="bk_pop" href="#gata1.REF.balduini.2004.129">Balduini et al 2004</a>; <a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</a>; Raskind, unpublished observations].</p><ul><li class="half_rhythm"><div>Platelet counts may be normal or mildly to moderately decreased [<a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al 2000</a>]; this may depend on the nature of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> or other (either genetic or environmental) modifiers.</div></li><li class="half_rhythm"><div>Morphologic abnormalities of platelets can be detected by electron microscopy [<a class="bk_pop" href="#gata1.REF.white.2007.620">White 2007</a>] and in some instances on peripheral blood smears [<a class="bk_pop" href="#gata1.REF.tubman.2007.3297">Tubman et al 2007</a>].</div></li><li class="half_rhythm"><div>Two distinct platelet morphologies can be observed on peripheral blood smear, reflecting <a class="def" href="/books/n/gene/glossary/def-item/mosaicism/">mosaicism</a> secondary to random <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a>.</div></li></ul><p><b>Course and prognosis</b>. The long-term course in both males and females depends on disease severity:</p><ul><li class="half_rhythm"><div>At the extreme end of the clinical spectrum, severe hemorrhage and/or erythrocyte transfusion dependence are life long.</div></li><li class="half_rhythm"><div>At the milder end, the risk for bleeding may spontaneously decrease with age, despite continued thrombocytopenia [<a class="bk_pop" href="#gata1.REF.mehaffey.2001.2681">Mehaffey et al 2001</a>, <a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</a>].</div></li><li class="half_rhythm"><div>Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may be recognized only after incidental findings of mild to moderate cytopenias on blood count analysis. These individuals have a good prognosis.</div></li></ul></div><div id="gata1.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p><a class="figpopup" href="/books/NBK1364/table/gata1.T.genotypephenotype_correlations/?report=objectonly" target="object" rid-figpopup="figgata1Tgenotypephenotypecorrelations" rid-ob="figobgata1Tgenotypephenotypecorrelations">Table 2</a> outlines the relationship between specific <i>GATA1</i> pathogenic variants and associated phenotypic features.</p><div id="gata1.T.genotypephenotype_correlations" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Genotype-Phenotype Correlations</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1364/table/gata1.T.genotypephenotype_correlations/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gata1.T.genotypephenotype_correlations_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pathogenic Variant&#x000a0;<sup>1</sup></th><th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Platelet Phenotype&#x000a0;<sup>2</sup></th><th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Platelet Aggregation</th><th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Red Cell Phenotype</th><th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other Features</th><th id="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">References</th></tr></thead><tbody><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Val205Met</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;<br />Large</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not studied</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;<br />Dyserythropoietic, fetal hydrops</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cryptorchidism&#x000a0;<sup>3</sup></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al [2000]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Gly208Ser</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;<br />Large</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Decreased</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.mehaffey.2001.2681">Mehaffey et al [2001]</a>&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Gly208Arg</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;&#x02193;<br />Large</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not studied</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;<br />Dyserythropoietic</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cryptorchidism in <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> but also in 2 sibs with wild type <i>GATA1</i>&#x000a0;<sup>3</sup></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al [2005]</a>, <a class="bk_pop" href="#gata1.REF.kratz.2008.432">Kratz et al [2008]</a>&#x000a0;<sup>4,&#x000a0;5</sup></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Arg216Gln</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;<br />Large</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal, but prolonged bleeding time</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild &#x003b2;-thalassemia, mild anemia</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Splenomegaly</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.thompson.1977.303">Thompson et al [1977]</a>, <a class="bk_pop" href="#gata1.REF.raskind.2000.2262">Raskind et al [2000]</a>, <a class="bk_pop" href="#gata1.REF.yu.2002.2040">Yu et al [2002]</a>, <a class="bk_pop" href="#gata1.REF.balduini.2004.129">Balduini et al [2004]</a>, <a class="bk_pop" href="#gata1.REF.hughan.2005.4369">Hughan et al [2005]</a>, <a class="bk_pop" href="#gata1.REF.tubman.2007.3297">Tubman et al [2007]</a>, <a class="bk_pop" href="#gata1.REF.campbell.2013.5218">Campbell et al [2013]</a>, &#x001fa;str&#x000f6;m et al [2015]</td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Arg216Trp</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not reported</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild &#x003b2;-thalassemia</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital erythropoietic porphyria, splenomegaly</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.hindmarsh.1986.1255">Hindmarsh [1986]</a>, <a class="bk_pop" href="#gata1.REF.phillips.2007.2618">Phillips et al [2007]</a>, <a class="bk_pop" href="#gata1.REF.ged.2009.53">Ged et al [2009]</a>, <a class="bk_pop" href="#gata1.REF.campbell.2013.5218">Campbell et al [2013]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Asp218Gly</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;<br />Large</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Decreased</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dyserythropoiesis without anemia</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.freson.2001.85">Freson et al [2001]</a>, <a class="bk_pop" href="#gata1.REF.white.2007.620">White [2007]</a>, <a class="bk_pop" href="#gata1.REF.white.2007.436">White et al [2007]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Asp218Tyr</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;&#x02193;<br />Large</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not studied</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Severe anemia</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Platelets in <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> female expressed only wild type <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.freson.2002.147">Freson et al [2002]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Ter414ArgextTer42</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;<br />Large</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not studied</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Lu(a-b-) red cells</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.singleton.2013.139">Singleton et al [2013]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">332G&#x0003e;C</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal counts, but dysplastic megakaryocytes</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Decreased</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Macrocytic anemia of variable severity</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Neutropenia</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al [2006]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Val74Leu</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal or &#x02193;</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not studied</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Macrocytic anemia of variable severity</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al [2012]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">c.220+1delG</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not studied</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anemia</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al [2012]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">c.220G&#x0003e;C</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not studied</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Macrocytic anemia</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.klar.2014.949">Klar et al [2014]</a></td></tr><tr><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">p.Met1_Cys83del</a></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02193;</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not studied</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Anemia</td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_gata1.T.genotypephenotype_correlations_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#gata1.REF.parrella.2014.1319">Parrella et al [2014]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gata1.TF.2.1"><p class="no_margin">See <a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">Table 4</a> for details.</p></div></dd><dt>2. </dt><dd><div id="gata1.TF.2.2"><p class="no_margin">Decreased platelet alpha granules are observed in all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males studied.</p></div></dd><dt>3. </dt><dd><div id="gata1.TF.2.3"><p class="no_margin">Cryptorchidism has been reported in several males with <i>GATA1</i> pathogenic variants [<a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al 2000</a>, <a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</a>]. Although <i>Gata1</i> is expressed in mouse testis, knockout of <i>Gata1</i> in Sertoli cells within the testis had no effect, suggesting that <i>Gata1</i> is not essential for Sertoli cell function [<a class="bk_pop" href="#gata1.REF.lindeboom.2003.5405">Lindeboom et al 2003</a>]. The independent <a class="def" href="/books/n/gene/glossary/def-item/segregation/">segregation</a> of cryptorchidism and <i>GATA1</i> pathogenic variants in one of the two families [<a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</a>], in conjunction with the mouse data, make the mechanistic relationship between <i>GATA1</i> pathogenic variants and cryptorchidism unclear at this point.</p></div></dd><dt>4. </dt><dd><div id="gata1.TF.2.4"><p class="no_margin">No response to splenectomy and/or steroids</p></div></dd><dt>5. </dt><dd><div id="gata1.TF.2.5"><p class="no_margin">Decreased bleeding episodes with age, despite persistence of thrombocytopenia</p></div></dd></dl></div></div></div><p>For further information on murine and in vitro experiments involving GATA-1, see <a href="#gata1.Molecular_Genetics">Molecular Genetics</a>, <b>Pathogenic variants</b>.</p></div><div id="gata1.Nomenclature"><h3>Nomenclature</h3><p>Until pathogenic variants in <i>GATA1</i> were shown to underlie this heterogeneous disorder, a variety of terms were coined for the different clinical presentations. The first term used was <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> thrombocytopenia with thalassemia (XLTT) [<a class="bk_pop" href="#gata1.REF.raskind.2000.2262">Raskind et al 2000</a>]. Other terms used in the past and still in the current literature are "<a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> dyserythropoietic anemia and thrombocytopenia" [<a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al 2000</a>, <a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</a>] and "X-linked macrothrombocytopenia" [<a class="bk_pop" href="#gata1.REF.freson.2001.85">Freson et al 2001</a>].</p><p>To describe individuals with a clinical diagnosis of <a href="/books/n/gene/diamond-b/">Diamond-Blackfan anemia</a> in whom <i>GATA1</i> pathogenic variants are identified and ribosomal protein variants are absent, the authors suggest the phrase "variant DBA associated with <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> of <i>GATA1</i>."</p></div><div id="gata1.Prevalence"><h3>Prevalence</h3><p><i>GATA1</i>-related cytopenia is rare; the prevalence is not known. To date, hematopoietic disease caused by inherited pathogenic variants in <i>GATA1</i> has been reported in 22 families [<a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al 2000</a>, <a class="bk_pop" href="#gata1.REF.freson.2001.85">Freson et al 2001</a>, <a class="bk_pop" href="#gata1.REF.mehaffey.2001.2681">Mehaffey et al 2001</a>, <a class="bk_pop" href="#gata1.REF.freson.2002.147">Freson et al 2002</a>, <a class="bk_pop" href="#gata1.REF.yu.2002.2040">Yu et al 2002</a>, <a class="bk_pop" href="#gata1.REF.balduini.2004.129">Balduini et al 2004</a>, <a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</a>, <a class="bk_pop" href="#gata1.REF.hughan.2005.4369">Hughan et al 2005</a>, <a class="bk_pop" href="#gata1.REF.phillips.2005.515a">Phillips et al 2005</a>, <a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>, <a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>, <a class="bk_pop" href="#gata1.REF.singleton.2013.139">Singleton et al 2013</a>, <a class="bk_pop" href="#gata1.REF.hermans.2014.305">Hermans et al 2014</a>, <a class="bk_pop" href="#gata1.REF.klar.2014.949">Klar et al 2014</a>, <a class="bk_pop" href="#gata1.REF.parrella.2014.1319">Parrella et al 2014</a>, <a class="bk_pop" href="#gata1.REF._str_m.2015.e44">&#x000c5;str&#x000f6;m et al 2015</a>, <a class="bk_pop" href="#gata1.REF.di_pierro.2015.491">Di Pierro et al 2015</a>, <a class="bk_pop" href="#gata1.REF.zucker.2016.917">Zucker et al 2016</a>].</p><p><i>GATA1</i> pathogenic variants may be more common than previously appreciated, particularly in persons with mild, unexplained thrombocytopenia/"gray platelet syndrome" present since birth [<a class="bk_pop" href="#gata1.REF.tubman.2007.3297">Tubman et al 2007</a>] or individuals with <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hypoplastic anemia/Diamond-Blackfan anemia with no ribosomal protein pathogenic variants [<a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>].</p></div></div><div id="gata1.Genetically_Related_Allelic_Disord"><h2 id="_gata1_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p><b>"Gray platelet syndrome" (GPS)</b> is a term that has been used to describe a genetically heterogeneous group of <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> disorders in which the platelets are large and have a gray appearance on light microscopy (Wright-stained slides) and the platelet alpha granules are either absent or reduced in numbers on electron microscopy. One family with a <a class="figpopup" href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object" rid-figpopup="figgata1Tgata1pathogenicvariantsdiscus" rid-ob="figobgata1Tgata1pathogenicvariantsdiscus">c.647G&#x0003e;A</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>GATA1</i> was reported to have GPS [<a class="bk_pop" href="#gata1.REF.tubman.2007.3297">Tubman et al 2007</a>]; however, in general, GPS is not associated with <i>GATA1</i> (see <a href="#gata1.Differential_Diagnosis">Differential Diagnosis</a>).</p><p><a href="/books/n/gene/diamond-b/"><b>Diamond Blackfan anemia</b></a>
<b>(DBA)</b> in its classic form is characterized by a profound normochromic and usually macrocytic anemia with normal leukocytes and platelets, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations in up to 50% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, and growth restriction in 30%. DBA has been associated with pathogenic variants in more than ten ribosomal protein (RP)-encoding genes. In several unrelated DBA probands with no <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> detected in any of the RP-encoding genes, affected individuals harbor pathogenic frameshift or <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants in <i>GATA1</i> that result in the exclusive production of an amino terminal truncated protein termed "GATA-1 short" (GATA-1s) [<a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>, <a class="bk_pop" href="#gata1.REF.klar.2014.949">Klar et al 2014</a>, <a class="bk_pop" href="#gata1.REF.parrella.2014.1319">Parrella et al 2014</a>, <a class="bk_pop" href="#gata1.REF.zucker.2016.917">Zucker et al 2016</a>]. Thus, GATA-1s-producing pathogenic variants result in a phenocopy of DBA that is not associated with growth restriction or congenital abnormalities occurring with pathogenic variants in any of the RP-encoding genes (see <a href="#gata1.Nomenclature">Nomenclature</a>).</p></div><div id="gata1.Differential_Diagnosis"><h2 id="_gata1_Differential_Diagnosis_">Differential Diagnosis</h2><p><i>GATA1</i>-related cytopenia must be distinguished from other acquired and inherited thrombocytopenias and platelet function abnormalities [<a class="bk_pop" href="#gata1.REF.balduini.2004.513">Balduini &#x00026; Savoia 2004</a>, <a class="bk_pop" href="#gata1.REF.drachman.2004.390">Drachman 2004</a>] (see <a class="figpopup" href="/books/NBK1364/table/gata1.T.etiology_and_characteristics_of/?report=objectonly" target="object" rid-figpopup="figgata1Tetiologyandcharacteristicsof" rid-ob="figobgata1Tetiologyandcharacteristicsof">Table 3</a>). Algorithms exist to help differentiate among these disorders [<a class="bk_pop" href="#gata1.REF.drachman.2004.390">Drachman 2004</a>, <a class="bk_pop" href="#gata1.REF.noris.2004.1219">Noris et al 2004</a>].</p><p>Because of its <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> and association with thrombocytopenia, <a href="/books/n/gene/was/">Wiskott-Aldrich syndrome</a> (WAS) can be confused with <i>GATA1</i>-related cytopenia. Distinguishing features of WAS include small platelets, eczema (~80%), and immunodeficiency, although individuals with milder pathogenic variants may manifest with microthrombocytopenia only.</p><p>In <i>GATA1</i>-related cytopenia, platelets are usually large and may be hypogranular. Relatively common <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> causes of <b>macrothrombocytopenia</b> that could potentially be confused with <i>GATA1</i>-related disorders are described in <a class="figpopup" href="/books/NBK1364/table/gata1.T.etiology_and_characteristics_of/?report=objectonly" target="object" rid-figpopup="figgata1Tetiologyandcharacteristicsof" rid-ob="figobgata1Tetiologyandcharacteristicsof">Table 3</a>.</p><div id="gata1.T.etiology_and_characteristics_of" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Etiology and Characteristics of Other Inherited Syndromes of Macrothrombocytopenia</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1364/table/gata1.T.etiology_and_characteristics_of/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gata1.T.etiology_and_characteristics_of_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Name</th><th id="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mode of Inheritance</th><th id="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Features</th></tr></thead><tbody><tr><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bernard-Soulier syndrome<br />(OMIM <a href="http://omim.org/entry/231200" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">231200</a>)</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GP1BA</i><br /><i>GP1BB</i><br /><i>GP9</i></td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR&#x000a0;<sup>1</sup></td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Severely defective ristocetin-induced platelet agglutination</div></li><li class="half_rhythm"><div>Severe bleeding disorder</div></li></ul>
</td></tr><tr><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/myh9/"><i>MYH9</i>-related syndromes</a></td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYH9</i></td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neutrophil inclusions</div></li><li class="half_rhythm"><div>Hearing loss, cataract, or renal defects variably present</div></li></ul>
</td></tr><tr><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mediterranean thrombocytopenia<br />(OMIM <a href="http://omim.org/entry/153670" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">153670</a>)</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>GP1BA</i></td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Dysmegakaryo-cytopoiesis</div></li></ul>
</td></tr><tr><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Paris-Trousseau thrombocytopenia<br />(OMIM <a href="http://omim.org/entry/188025" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">188025</a>)</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 2</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Cardiac and facial abnormalities</div></li><li class="half_rhythm"><div>Intellectual disability</div></li></ul>
</td></tr><tr><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Jacobsen syndrome<br />(OMIM <a href="http://omim.org/entry/147791" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">147791</a>)</td></tr><tr><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/gr_22q11deletion/">22q11.2 deletion syndrome</a></td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 3</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Facial and cardiac abnormalities</div></li><li class="half_rhythm"><div>Intellectual disability</div></li><li class="half_rhythm"><div>Psychiatric disorders</div></li></ul>
</td></tr><tr><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gray platelet syndrome<br />(OMIM <a href="http://omim.org/entry/139090" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">139090</a>)</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NBEAL2</i><br /><i>GATA1</i>&#x000a0;<sup>4</sup></td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 5</td><td headers="hd_h_gata1.T.etiology_and_characteristics_of_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Pale platelets</div></li><li class="half_rhythm"><div>Reduced or absent &#x003b1;-granules</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="gata1.TF.3.1"><p class="no_margin">Heterozygotes may have mild disease.</p></div></dd><dt>2. </dt><dd><div id="gata1.TF.3.2"><p class="no_margin">Paris-Trousseau thrombocytopenia and Jacobsen syndrome are <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion/">contiguous gene deletion</a> syndromes.</p></div></dd><dt>3. </dt><dd><div id="gata1.TF.3.3"><p class="no_margin"><a href="/books/n/gene/gr_22q11deletion/">22q11.2 deletion syndrome</a> is a <a class="def" href="/books/n/gene/glossary/def-item/contiguous-gene-deletion-syndrome/">contiguous gene deletion syndrome</a>.</p></div></dd><dt>4. </dt><dd><div id="gata1.TF.3.4"><p class="no_margin">One person with an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> form of this syndrome was found to have a <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#gata1.REF.wechsler.2002.148">Wechsler et al 2002</a>, <a class="bk_pop" href="#gata1.REF.tubman.2007.3297">Tubman et al 2007</a>] (see <a href="#gata1.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>).</p></div></dd><dt>5. </dt><dd><div id="gata1.TF.3.5"><p class="no_margin">Most cases of GPS are <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> (i.e., a single occurrence in a family), but sibships with unaffected, often <a class="def" href="/books/n/gene/glossary/def-item/consanguineous/">consanguineous</a> parents consistent with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a> and families with apparent <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> or <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> transmission have been reported [reviewed in <a class="bk_pop" href="#gata1.REF.nurden.2007.21">Nurden &#x00026; Nurden 2007</a>].</p></div></dd></dl></div></div></div></div><div id="gata1.Management"><h2 id="_gata1_Management_">Management</h2><div id="gata1.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with <i>GATA1</i>-related cytopenia, the following are recommended:</p><ul><li class="half_rhythm"><div class="half_rhythm">Complete blood count and examination of the peripheral smear to assess the degree of cytopenia(s)</div></li><li class="half_rhythm"><div class="half_rhythm">Detailed history of age at which hematologic disease was manifest</div></li><li class="half_rhythm"><div class="half_rhythm">Documentation of abnormal/unexpected bleeding episodes and platelet counts obtained at the time of the episodes to help determine whether platelet function is abnormal and whether disease severity has changed over time</div><div class="half_rhythm">Note: Platelet aggregation studies may also be useful to identify functional abnormalities that predict a greater risk of bleeding for any given platelet count, but studies can be difficult to interpret when platelet counts are lower than 100,000/&#x003bc;L.</div></li><li class="half_rhythm"><div class="half_rhythm">Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="gata1.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Individuals with <i>GATA1</i>-related cytopenia are treated supportively.</p><p><b>Thrombocytopenia.</b> Individuals with moderate to severe epistaxis, gingival bleeding, or gastrointestinal bleeding should receive platelet transfusions. Transfusion requirements vary from person to person as bleeding can be related to quantitative and/or qualitative platelet defects.</p><ul><li class="half_rhythm"><div>For individuals with thrombocytopenia and/or platelet aggregation defects, DDAVP treatment may be helpful for short-term management of mild to moderate bleeding.</div></li><li class="half_rhythm"><div>Individuals who are only mildly symptomatic (easy bruisability without mucosal or more severe bleeding) do not require specific treatment.</div></li><li class="half_rhythm"><div>There is no evidence that splenectomy is beneficial in people with <i>GATA1</i>-related disease, although this treatment may be considered if splenomegaly is severe. Although splenectomy may improve the cytopenias, platelet dysfunction will not be improved.</div></li></ul><p><b>Anemia.</b> Erythrocyte transfusions are indicated when anemia is symptomatic (fatigue, tachycardia).</p><ul><li class="half_rhythm"><div>Iron overload and the development of alloantibodies may limit chronic transfusion therapy.</div></li><li class="half_rhythm"><div>Extended pre-transfusion red blood cell phenotyping and matching for minor erythrocyte antigens in individuals receiving frequent transfusions can reduce the risk of alloimmunization.</div></li></ul><p><b>Neutropenia.</b> Individuals with neutropenia who present with fever should be evaluated promptly with a physical examination, complete blood count, and blood culture and should receive appropriate parenteral antibiotics.</p><p><b>Bone marrow transplantation (BMT).</b> For severe cases, BMT can be curative [<a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>, <a class="bk_pop" href="#gata1.REF.phillips.2007.2618">Phillips et al 2007</a>, <a class="bk_pop" href="#gata1.REF.parrella.2014.1319">Parrella et al 2014</a>].</p><ul><li class="half_rhythm"><div>BMT should be considered in individuals with severe phenotypes of <i>GATA1</i>-related cytopenia, particularly if an HLA-matched donor is available.</div></li><li class="half_rhythm"><div>While BMT may offer a cure, clinical experience with BMT in this disease is limited and families must be counseled on the significant risks and morbidity associated with BMT.</div></li></ul></div><div id="gata1.Prevention_of_Primary_Manifestatio"><h3>Prevention of Primary Manifestations</h3><p>The only definitive cure for <i>GATA1</i>-related cytopenia is bone marrow transplantation.</p></div><div id="gata1.Prevention_of_Secondary_Complicati"><h3>Prevention of Secondary Complications</h3><p>Individuals with thrombocytopenia and/or platelet aggregation defects should receive a platelet transfusion prior to surgical or invasive dental procedures.</p><p>Individuals with neutropenia should be counseled regarding their increased risk of infection. They should avoid crowds and contact with individuals who have communicable diseases. When febrile, those who are severely neutropenic (absolute neutrophil count &#x0003c;500/&#x000b5;L) should seek medical attention; typically blood cultures are obtained and parenteral antibiotics are administered to avoid the possibility of life-threatening sepsis.</p></div><div id="gata1.Surveillance"><h3>Surveillance</h3><p>Depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the disease, complete blood counts should be monitored so that supportive care can be provided as needed. Individuals with mild cytopenias require infrequent monitoring (yearly), while those with severe cytopenias who require transfusions should have complete blood counts monthly or as indicated by clinical signs and symptoms.</p><p>Individuals undergoing repeated erythrocyte transfusions should be monitored for iron overload and managed appropriately with iron chelation therapy.</p></div><div id="gata1.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Individuals with thrombocytopenia should avoid antiplatelet agents including aspirin and nonsteroidal anti-inflammatory agents (e.g., ibuprofen).</p><p>Individuals with thrombocytopenia and/or platelet aggregation defects should be advised to avoid contact sports or activities with a high risk of trauma.</p><p>Individuals with significant neutropenia should avoid crowds and close contact with persons who have a communicable disease to minimize risk of infection.</p><p>Individuals with significant splenomegaly should avoid contact sports, which involve increased risk for traumatic splenic rupture.</p></div><div id="gata1.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from prompt initiation of treatment and preventive measures.</p><p>Evaluations can include:</p><ul><li class="half_rhythm"><div class="half_rhythm">Molecular genetic testing for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>;</div></li><li class="half_rhythm"><div class="half_rhythm">A screening complete blood count to evaluate for thrombocytopenia, anemia, or neutropenia.</div><div class="half_rhythm">Note: Platelet, erythrocyte, and neutrophil counts can vary significantly in individuals with <i>GATA1</i> pathogenic variants; normal results do not rule out the possibility that the relative has a <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li></ul><p>See <a href="#gata1.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="gata1.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="https://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="gata1.Other"><h3>Other</h3><p>Unlike immune-mediated platelet disorders such as immune thrombocytopenic purpura, <i>GATA1</i>-related thrombocytopenia does not respond to steroid or immunoglobulin therapy.</p><p>Supplemental erythropoietin therapy is unlikely to be effective because the anemia is secondary to ineffective erythropoiesis, not erythropoietin deficiency.</p></div></div><div id="gata1.Genetic_Counseling"><h2 id="_gata1_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="gata1.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p><i>GATA1</i>-related cytopenia is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner.</p></div><div id="gata1.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>; therefore, he does not require further evaluation/testing.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>). If a woman has more than one affected son and no other affected relatives and if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (evidence of germline mosaicism has not been observed).</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier. Because very few families with <i>GATA1</i> pathogenic variants have been described to date, the frequency of <i>de novo</i> pathogenic variants is not known.</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%.</div><ul><li class="half_rhythm"><div>Males who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li><li class="half_rhythm"><div>Females who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> and will usually not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, but may have reduced hematocrits and platelet counts to a variable degree. Large platelets may also be present and those with the globin chain imbalance subtype may have splenomegaly and slightly decreased &#x003b2;-globin synthesis.</div></li></ul></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of maternal <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Affected males transmit the <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to:</p><ul><li class="half_rhythm"><div>All of their daughters, who will be carriers (heterozygotes) and will usually not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> (see <a href="#gata1.Clinical_Description">Clinical Description</a>);</div></li><li class="half_rhythm"><div>None of their sons.</div></li></ul><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being heterozygotes (carriers) for the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and the aunts' offspring, depending on their gender, may be at risk of being heterozygotes (carriers) for the pathogenic variant or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="gata1.Heterozygote_Carrier_Detection"><h3>Heterozygote (Carrier) Detection</h3><p>Molecular genetic testing of at-risk female relatives to determine their genetic status is most informative if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</p><p>Note: Females who are heterozygotes (carriers) for this <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder may develop clinical findings related to the disorder (see <a href="#gata1.Clinical_Description">Clinical Description</a>).</p></div><div id="gata1.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#gata1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="gata1.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>GATA1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for <i>GATA1</i>-related cytopenia are possible.</p></div></div><div id="gata1.Resources"><h2 id="_gata1_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Platelet Disorder Support Association (PDSA)</b></div><div>8751 Brecksville Road</div><div>Suite 150</div><div>Cleveland OH 44141</div><div><b>Phone:</b> 877-528-3538 (toll-free); 440-746-9003</div><div><b>Fax:</b> 844-270-1277</div><div><b>Email:</b> pdsa@pdsa.org</div><div><a href="http://www.pdsa.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.pdsa.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000586.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Thrombocytopenia</a></div></li></ul></div><div id="gata1.Molecular_Genetics"><h2 id="_gata1_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="gata1.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>GATA1-Related X-Linked Cytopenia: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1364/table/gata1.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gata1.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_gata1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_gata1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_gata1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_gata1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_gata1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_gata1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_gata1.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2623" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>GATA1</i></a></td><td headers="hd_b_gata1.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2623" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xp11<wbr style="display:inline-block"></wbr>​.23</a></td><td headers="hd_b_gata1.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P15976" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Erythroid transcription factor</a></td><td headers="hd_b_gata1.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/GATA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GATA1 @ LOVD</a></td><td headers="hd_b_gata1.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=GATA1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GATA1</a></td><td headers="hd_b_gata1.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=GATA1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">GATA1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="gata1.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="gata1.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for GATA1-Related X-Linked Cytopenia (<a href="/omim/300367,305371,314050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1364/table/gata1.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gata1.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300367" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300367</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA; XLTDA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/305371" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">305371</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GATA-BINDING PROTEIN 1; GATA1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/314050" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">314050</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT</td></tr></tbody></table></div></div><p><b>Gene structure.</b>
<i>GATA1</i> has six exons, although the first <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> is non-coding and is not counted in some of the literature. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1364/#gata1.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> <i>GATA1</i> variants associated with cytopenias are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants. These variants cluster in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 4 amino acid residues 205, 208, 216, and 218 within the amino-terminal zinc finger <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. They either affect erythroid <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> (GATA-1) binding to DNA or interaction of GATA-1 with its essential cofactor, friend of GATA (FOG)-1 [<a class="bk_pop" href="#gata1.REF.nichols.2000.266">Nichols et al 2000</a>, <a class="bk_pop" href="#gata1.REF.freson.2001.85">Freson et al 2001</a>, <a class="bk_pop" href="#gata1.REF.mehaffey.2001.2681">Mehaffey et al 2001</a>, <a class="bk_pop" href="#gata1.REF.freson.2002.147">Freson et al 2002</a>, <a class="bk_pop" href="#gata1.REF.yu.2002.2040">Yu et al 2002</a>, <a class="bk_pop" href="#gata1.REF.balduini.2004.129">Balduini et al 2004</a>, <a class="bk_pop" href="#gata1.REF.del_vecchio.2005.113">Del Vecchio et al 2005</a>].</p><p>A <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 of <i>GATA1</i> that alters <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> was found in one family with anemia and neutropenia [<a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>]. Similar variants have been identified in several families with <a href="/books/n/gene/diamond-b/">Diamond-Blackfan anemia</a> without pathogenic ribosomal protein variants [<a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>, <a class="bk_pop" href="#gata1.REF.parrella.2014.1319">Parrella et al 2014</a>, <a class="bk_pop" href="#gata1.REF.klar.2014.949">Klar et al 2014</a>, <a class="bk_pop" href="#gata1.REF.zucker.2016.917">Zucker et al 2016</a>] and unpublished studies by several groups. These variants result in the exclusive production of an amino-truncated isoform of GATA-1, termed GATA-1s (for GATA-1 short; also discussed in <a href="#gata1.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>). In the context of Down syndrome (DS, trisomy 21), somatic variants resulting in the production of only GATA-1s are associated with leukemia and transient myeloproliferative disorder (TMD) [<a class="bk_pop" href="#gata1.REF.wechsler.2002.148">Wechsler et al 2002</a>]; however, the same <i>GATA1</i> variants present in the <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> of persons who do not have DS cause cytopenia but not leukemia [<a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al 2006</a>]. In mice, analogous variants increase the proliferative capacity of embryonic megakaryocyte precursors but produce a minimal hematopoietic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> in adults [<a class="bk_pop" href="#gata1.REF.li.2005.613">Li et al 2005</a>].</p><p><i>Cis</i> element variants affecting GATA-1 binding to target genes have also been implicated in red cell production or function. For example, Africans frequently carry a variant in the Duffy antigen/chemokine receptor (<i>DARC</i>) <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> promoter that disrupts GATA-1 binding [<a class="bk_pop" href="#gata1.REF.tournamille.1995.224">Tournamille et al 1995</a>]. This leads to the common African Duffy negative red cell <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, which confers resistance to <i>Plasmodium vivax</i> malaria.</p><p><a href="/books/n/gene/cep/">Congenital erythropoietic porphyria</a> (CEP) can also be caused by variants in the <a class="def" href="/books/n/gene/glossary/def-item/promoter-region/">promoter region</a> of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding the heme synthetic enzyme uroporphyrinogen III synthase, where GATA-1 normally binds [<a class="bk_pop" href="#gata1.REF.solis.2001.753">Solis et al 2001</a>].</p><p><a href="/books/n/gene/sider-anemia/">X-linked sideroblastic anemia</a> (XLSA) typically results from partial <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in the erythroid-specific heme biosynthesis protein 5-aminolevulinate synthase 2 (<i>ALAS2</i>). Variants in the GATA binding site located in a transcriptional enhancer element in <i>ALAS2</i> have been identified in several pedigrees with XLSA [<a class="bk_pop" href="#gata1.REF.campagna.2014.315">Campagna et al 2014</a>, <a class="bk_pop" href="#gata1.REF.kaneko.2014.252">Kaneko et al 2014</a>].</p><p>As a master regulator of erythrocyte and megakaryocyte/platelet development, <i>GATA1</i> both activates and represses hundreds of genes in each of these lineages. Presumably, different <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants in <i>GATA1</i> cause distinct phenotypes by altering the expression of specific subsets of target genes. These pathogenic variants could affect GATA1 DNA binding, interactions with cofactors, or both. Both of these properties of the GATA zinc fingers have been mapped by structural studies. However, recent analysis of <i>GATA1</i> pathogenic variants in murine complementation systems showed that structural studies and in vitro examination of purified recombinant proteins did not always accurately elucidate the effects of variants, and in vivo studies are required [<a class="bk_pop" href="#gata1.REF.campbell.2013.5218">Campbell et al 2013</a>]. Specifically, p.Arg216Gln and p.Arg216Trp variants that impaired DNA binding in vitro did not measurably affect in vivo target <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> occupancy. Instead, diminished TAL1 complex recruitment to GATA-1 target genes was implicated. Thus, establishing <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> relationships in <i>GATA1</i>-associated anemias and thrombocytopenias presents a complex but worthwhile challenge that will likely elucidate general concepts of <a class="def" href="/books/n/gene/glossary/def-item/transcription-factor/">transcription factor</a> function and human disease.</p><div id="gata1.T.gata1_pathogenic_variants_discus" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>GATA1</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1364/table/gata1.T.gata1_pathogenic_variants_discus/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__gata1.T.gata1_pathogenic_variants_discus_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change<br />(Alias&#x000a0;<sup>1</sup>)</th><th id="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.2T&#x0003e;C</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Met1_Cys83del&#x000a0;<sup>2</sup></td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_3" rowspan="12" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_002049.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_002049<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_002040.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_002040<wbr style="display:inline-block"></wbr>​.1</a></td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.220G&#x0003e;C&#x000a0;<sup>3</sup></td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val74Leu</td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.220+1delG&#x000a0;<sup>4</sup></td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.613G&#x0003e;A</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val205Met</td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.622_623delGGinsTC<br />(622_623GG&#x0003e;TC)</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly208Ser</td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.622G&#x0003e;C</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Gly208Arg</td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.647G&#x0003e;A</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg216Gln&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.646C&#x0003e;T</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Arg216Trp</td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(332G&#x0003e;C)&#x000a0;<sup>6</sup></td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.652G&#x0003e;T</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp218Tyr</td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.653A&#x0003e;G</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp218Gly</td></tr><tr><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.1240T&#x0003e;C</td><td headers="hd_h_gata1.T.gata1_pathogenic_variants_discus_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ter414ArgextTer42&#x000a0;<sup>7</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt></dt><dd><div><p class="no_margin">See <a class="figpopup" href="/books/NBK1364/table/gata1.T.genotypephenotype_correlations/?report=objectonly" target="object" rid-figpopup="figgata1Tgenotypephenotypecorrelations" rid-ob="figobgata1Tgenotypephenotypecorrelations">Table 2</a> for <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a>.</p></div></dd><dt>1. </dt><dd><div id="gata1.TF.4.1"><p class="no_margin">Variant designation that does not conform to current naming conventions</p></div></dd><dt>2. </dt><dd><div id="gata1.TF.4.2"><p class="no_margin">Obliterates initiation codon; alternative initiation Met84 residue is used, resulting in lack of full length <a class="def" href="/books/n/gene/glossary/def-item/cdna/">cDNA</a> [<a class="bk_pop" href="#gata1.REF.parrella.2014.1319">Parrella et al 2014</a>].</p></div></dd><dt>3. </dt><dd><div id="gata1.TF.4.3"><p class="no_margin">Alternation of the last nucleotide of <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2; predicted to affect <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> [<a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>]</p></div></dd><dt>4. </dt><dd><div id="gata1.TF.4.4"><p class="no_margin">Exon skipping and frame shift are predicted because the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> affects the canonic splice donor site [<a class="bk_pop" href="#gata1.REF.sankaran.2012.2439">Sankaran et al 2012</a>].</p></div></dd><dt>5. </dt><dd><div id="gata1.TF.4.5"><p class="no_margin">Also reported in one family with "gray platelet syndrome" (see <a href="#gata1.Genetically_Related_Allelic_Disord">Genetically Related Disorders</a>)</p></div></dd><dt>6. </dt><dd><div id="gata1.TF.4.6"><p class="no_margin">Pathogenic variant alias reported in <a class="bk_pop" href="#gata1.REF.hollanda.2006.807">Hollanda et al [2006]</a></p></div></dd><dt>7. </dt><dd><div id="gata1.TF.4.7"><p class="no_margin">Pathogenic variant in stop codon 414 results in addition of 41 amino acids and use of new stop codon at residue 42 [<a class="bk_pop" href="#gata1.REF.singleton.2013.139">Singleton et al 2013</a>].</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>GATA1</i> encodes a nuclear protein of 413 amino acid residues that contains two zinc fingers and an acidic amino terminal <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> that can function as a transcriptional activator [<a class="bk_pop" href="#gata1.REF.ferreira.2005.1215">Ferreira et al 2005</a>, <a class="bk_pop" href="#gata1.REF.lowry.2006.6">Lowry &#x00026; Mackay 2006</a>]. The C-terminal zinc finger is responsible for DNA binding activity for most or all target genes and the N-terminal zinc finger plays a role in stabilization of GATA-1 binding to DNA at a subset of target sites containing duplicated or palindromic GATA-1 motifs [<a class="bk_pop" href="#gata1.REF.ohneda.2002.237">Ohneda &#x00026; Yamamoto 2002</a>]. The N-f is also critical for binding of GATA-1 to numerous partner proteins, including FOG1, an essential factor required for many GATA-1 functions [<a class="bk_pop" href="#gata1.REF.tsang.1997.109">Tsang et al 1997</a>, <a class="bk_pop" href="#gata1.REF.fox.1999.2812">Fox et al 1999</a>]. GATA-1 is expressed in hematopoietic lineages and in Sertoli cells of testis. Gene targeting studies in mice indicate that GATA-1 is essential for the development of erythrocyte, megakaryocyte, mast cell, and eosinophil lineages. It is not known whether individuals with inherited <i>GATA1</i> pathogenic variants have defects in the latter two cell lineages.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> All pathogenic variants are <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants, indels, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, or <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> substitutions resulting in the production of an abnormal protein. Missense variants in N-f affect its ability to bind either <i>GATA1</i> sites in DNA, the cofactor FOG1, or both. Splice site variants result in a short form of the protein, GATA-1s. Mice genetically engineered to express GATA-1s show prenatal anemia and megakaryocyte proliferation, but newborn and adult mice display no hematopoietic abnormalities [<a class="bk_pop" href="#gata1.REF.li.2005.613">Li et al 2005</a>]. The functions of these abnormal proteins and their relationship to disease phenotypes are discussed in <a href="#gata1.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</a> and in <a class="figpopup" href="/books/NBK1364/table/gata1.T.genotypephenotype_correlations/?report=objectonly" target="object" rid-figpopup="figgata1Tgenotypephenotypecorrelations" rid-ob="figobgata1Tgenotypephenotypecorrelations">Table 2</a>.</p><div id="gata1.Cancer_and_Benign_Tumors"><h3>Cancer and Benign Tumors</h3><p>Two hematopoietic disorders in children with Down syndrome (DS) associated with acquired (somatic) pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 of <i>GATA1</i> are transient myeloproliferative disorder (TMD) and acute megakaryoblastic leukemia (M7 subtype, DS-AMKL) [<a class="bk_pop" href="#gata1.REF.wechsler.2002.148">Wechsler et al 2002</a>, <a class="bk_pop" href="#gata1.REF.elagib.2003.4333">Elagib et al 2003</a>, <a class="bk_pop" href="#gata1.REF.waltzer.2003.6516">Waltzer et al 2003</a>, <a class="bk_pop" href="#gata1.REF.ahmed.2004.2480">Ahmed et al 2004</a>, <a class="bk_pop" href="#gata1.REF.creutzig.2005.1355">Creutzig et al 2005</a>, <a class="bk_pop" href="#gata1.REF.crispino.2005a.137">Crispino 2005a</a>, <a class="bk_pop" href="#gata1.REF.crispino.2005b.40">Crispino 2005b</a>, <a class="bk_pop" href="#gata1.REF.muntean.2006.986">Muntean et al 2006</a>, <a class="bk_pop" href="#gata1.REF.roy.2009.3">Roy et al 2009</a>, <a class="bk_pop" href="#gata1.REF.roberts.2013.3908">Roberts et al 2013</a>].</p><p>TMD, found in up to 10% of infants with DS, usually resolves spontaneously; however, TMD confers a markedly increased risk for DS-AMKL [<a class="bk_pop" href="#gata1.REF.wechsler.2002.148">Wechsler et al 2002</a>, <a class="bk_pop" href="#gata1.REF.ahmed.2004.2480">Ahmed et al 2004</a>, <a class="bk_pop" href="#gata1.REF.crispino.2005a.137">Crispino 2005a</a>, <a class="bk_pop" href="#gata1.REF.crispino.2005b.40">Crispino 2005b</a>, <a class="bk_pop" href="#gata1.REF.hitzler.2005.11">Hitzler &#x00026; Zipursky 2005</a>]. The acquired <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 2 variants lead to premature arrest of translation and reinitiation of protein synthesis at the downstream methionine codon at position 83, and result in the production of GATA-1 short isoform (GATA-1s) that lacks the amino-terminal activation <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. Some <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants also result in generation of GATA-1s. Two novel <i>GATA1</i> variants involving internal deletions of either amino acids 77-199 or 74-88 were identified in six individuals with TMD [<a class="bk_pop" href="#gata1.REF.toki.2013.3181">Toki et al 2013</a>]. How <i>GATA1</i> variants synergize with trisomy 21 to promote DS-AMKL is unknown.</p><p>One individual with severe anemia and thrombocytopenia caused by a pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant in <i>GATA1</i> (p.Val205Met) developed myelodysplastic syndrome 18 years after a failed bone marrow transplantation. It is not clear whether the MDS with a clonal <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 20q was due to the underlying disease caused by the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> of <i>GATA1</i>, bone marrow transplant associated toxicity, or both [Authors, unpublished data].</p></div></div><div id="gata1.References"><h2 id="_gata1_References_">References</h2><div id="gata1.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.ahmed.2004.2480">Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P. Natural history of GATA1 mutations in Down syndrome. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">103</span>:2480–9.</span> [<a href="/pubmed/14656875" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14656875</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF._str_m.2015.e44">&#x000c5;str&#x000f6;m M, Hahn-Str&#x000f6;mberg V, Zetterberg E, Vedin I, Merup M, Palmblad J. X-linked thrombocytopenia with thalassemia displays bone marrow reticulin fibrosis and enhanced angiogenesis: comparisons with primary myelofibrosis. <span><span class="ref-journal">Am J Hematol. </span>2015;<span class="ref-vol">90</span>:E44–8.</span> [<a href="/pubmed/25421114" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25421114</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.balduini.2004.129">Balduini CL, Pecci A, Loffredo G, Izzo P, Noris P, Grosso M, Bergamaschi G, Rosti V, Magrini U, Ceresa IF, Conti V, Poggi V, Savoia A. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. <span><span class="ref-journal">Thromb Haemost. </span>2004;<span class="ref-vol">91</span>:129–40.</span> [<a href="/pubmed/14691578" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14691578</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.balduini.2004.513">Balduini CL, Savoia A. Inherited thrombocytopenias: molecular mechanisms. <span><span class="ref-journal">Semin Thromb Hemost. </span>2004;<span class="ref-vol">30</span>:513–23.</span> [<a href="/pubmed/15497094" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15497094</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.campagna.2014.315">Campagna DR, de Bie CI, Schmitz-Abe K, Sweeney M, Sendamarai AK, Schmidt PJ, Heeney MM, Yntema HG, Kannengiesser C, Grandchamp B, Niemeyer CM, Knoers NV, Swart S, Marron G, van Wijk R, Raymakers RA, May A, Markianos K, Bottomley SS, Swinkels DW, Fleming MD. X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA-binding site mutations. <span><span class="ref-journal">Am J Hematol. </span>2014;<span class="ref-vol">89</span>:315–9.</span> [<a href="/pmc/articles/PMC3943703/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3943703</span></a>] [<a href="/pubmed/24166784" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24166784</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.campbell.2013.5218">Campbell AE, Wilkinson-White L, Mackay JP, Matthews JM, Blobel GA. Analysis of disease-causing GATA1 mutations in murine gene complementation systems. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">121</span>:5218–27.</span> [<a href="/pmc/articles/PMC3695365/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3695365</span></a>] [<a href="/pubmed/23704091" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23704091</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.creutzig.2005.1355">Creutzig U, Reinhardt D, Diekamp S, Dworzak M, Stary J, Zimmermann M. AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity. <span><span class="ref-journal">Leukemia. </span>2005;<span class="ref-vol">19</span>:1355–60.</span> [<a href="/pubmed/15920490" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15920490</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.crispino.2005a.137">Crispino JD. GATA1 in normal and malignant hematopoiesis. <span><span class="ref-journal">Semin Cell Dev Biol. </span>2005a;<span class="ref-vol">16</span>:137–47.</span> [<a href="/pubmed/15659348" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15659348</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.crispino.2005b.40">Crispino JD. GATA1 mutations in Down syndrome: implications for biology and diagnosis of children with transient myeloproliferative disorder and acute megakaryoblastic leukemia. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2005b;<span class="ref-vol">44</span>:40–4.</span> [<a href="/pubmed/15390312" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15390312</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.del_vecchio.2005.113">Del Vecchio GC, Giordani L, De Santis A, De Mattia D. Dyserythropoietic anemia and thrombocytopenia due to a novel mutation in GATA-1. <span><span class="ref-journal">Acta Haematol. </span>2005;<span class="ref-vol">114</span>:113–6.</span> [<a href="/pubmed/16103636" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16103636</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.di_pierro.2015.491">Di Pierro E, Russo R, Karakas Z, Brancaleoni V, Gambale A, Kurt I, Winter SS, Granata F, Czuchlewski DR, Langella C, Iolascon A, Cappellini MD. Congenital erythropoietic porphyria linked to GATA1-R216W mutation: challenges for diagnosis. <span><span class="ref-journal">Eur J Haematol. </span>2015;<span class="ref-vol">94</span>:491–7.</span> [<a href="/pubmed/25251786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25251786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.drachman.2004.390">Drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. <span><span class="ref-journal">Blood. </span>2004;<span class="ref-vol">103</span>:390–8.</span> [<a href="/pubmed/14504084" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14504084</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.elagib.2003.4333">Elagib KE, Racke FK, Mogass M, Khetawat R, Delehanty LL, Goldfarb AN. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. <span><span class="ref-journal">Blood. </span>2003;<span class="ref-vol">101</span>:4333–41.</span> [<a href="/pubmed/12576332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12576332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.ferreira.2005.1215">Ferreira R, Ohneda K, Yamamoto M, Philipsen S. GATA1 function, a paradigm for transcription factors in hematopoiesis. <span><span class="ref-journal">Mol Cell Biol. </span>2005;<span class="ref-vol">25</span>:1215–27.</span> [<a href="/pmc/articles/PMC548021/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC548021</span></a>] [<a href="/pubmed/15684376" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15684376</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.fox.1999.2812">Fox AH, Liew C, Holmes M, Kowalski K, Mackay J, Crossley M. Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers. <span><span class="ref-journal">EMBO J. </span>1999;<span class="ref-vol">18</span>:2812–22.</span> [<a href="/pmc/articles/PMC1171362/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1171362</span></a>] [<a href="/pubmed/10329627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10329627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.freson.2001.85">Freson K, Devriendt K, Matthijs G, Van Hoof A, De Vos R, Thys C, Minner K, Hoylaerts MF, Vermylen J, Van Geet C. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation. <span><span class="ref-journal">Blood. </span>2001;<span class="ref-vol">98</span>:85–92.</span> [<a href="/pubmed/11418466" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11418466</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.freson.2002.147">Freson K, Matthijs G, Thys C, Marien P, Hoylaerts MF, Vermylen J, Van Geet C. Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. <span><span class="ref-journal">Hum Mol Genet. </span>2002;<span class="ref-vol">11</span>:147–52.</span> [<a href="/pubmed/11809723" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11809723</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.ged.2009.53">Ged C, Moreau-Gaudry F, Richard E, Robert-Richard E, de Verneuil H. Congenital erythropoietic porphyria: mutation update and correlations between genotype and phenotype. <span><span class="ref-journal">Cell Mol Biol (Noisy-le-grand). </span>2009;<span class="ref-vol">55</span>:53–60.</span> [<a href="/pubmed/19268002" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19268002</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.hermans.2014.305">Hermans C, De Waele L, Van Geet C, Freson K. Novel GATA1 mutation in residue D218 leads to macrothrombocytopenia and clinical bleeding problems. <span><span class="ref-journal">Platelets. </span>2014;<span class="ref-vol">25</span>:305–7.</span> [<a href="/pubmed/23971719" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23971719</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.hindmarsh.1986.1255">Hindmarsh JT. The porphyrias: recent advances. <span><span class="ref-journal">Clin Chem. </span>1986;<span class="ref-vol">32</span>:1255–63.</span> [<a href="/pubmed/3521939" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3521939</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.hitzler.2005.11">Hitzler JK, Zipursky A. Origins of leukaemia in children with Down syndrome. <span><span class="ref-journal">Nat Rev Cancer. </span>2005;<span class="ref-vol">5</span>:11–20.</span> [<a href="/pubmed/15630411" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15630411</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.hollanda.2006.807">Hollanda LM, Lima CS, Cunha AF, Albuquerque DM, Vassallo J, Ozelo MC, Joazeiro PP, Saad ST, Costa FF. An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:807–12.</span> [<a href="/pubmed/16783379" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16783379</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.hughan.2005.4369">Hughan SC, Senis Y, Best D, Thomas A, Frampton J, Vyas P, Watson SP. Selective impairment of platelet activation to collagen in the absence of GATA1. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">105</span>:4369–76.</span> [<a href="/pubmed/15701726" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15701726</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.kaneko.2014.252">Kaneko K, Furuyama K, Fujiwara T, Kobayashi R, Ishida H, Harigae H, Shibahara S. Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia. <span><span class="ref-journal">Haematologica. </span>2014;<span class="ref-vol">99</span>:252–61.</span> [<a href="/pmc/articles/PMC3912954/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3912954</span></a>] [<a href="/pubmed/23935018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23935018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.klar.2014.949">Klar J, Khalfallah A, Arzoo PS, Gazda HT, Dahl N. Recurrent GATA1 mutations in Diamond-Blackfan anaemia. <span><span class="ref-journal">Br J Haematol. </span>2014;<span class="ref-vol">166</span>:949–51.</span> [<a href="/pubmed/24766296" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24766296</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.kratz.2008.432">Kratz CP, Niemeyer CM, Karow A, Volz-Fleckenstein M, Schmitt-Gr&#x000e4;ff A, Strahm B. Congenital transfusion-dependent anemia and thrombocytopenia with myelodysplasia due to a recurrent GATA1(G208R) germline mutation. <span><span class="ref-journal">Leukemia. </span>2008;<span class="ref-vol">22</span>:432–4.</span> [<a href="/pubmed/17713552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17713552</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.li.2005.613">Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:613–9.</span> [<a href="/pubmed/15895080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15895080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.lindeboom.2003.5405">Lindeboom F, Gillemans N, Karis A, Jaegle M, Meijer D, Grosveld F, Philipsen S. A tissue-specific knockout reveals that Gata1 is not essential for Sertoli cell function in the mouse. <span><span class="ref-journal">Nucleic Acids Research. </span>2003;<span class="ref-vol">31</span>:5405–12.</span> [<a href="/pmc/articles/PMC203309/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC203309</span></a>] [<a href="/pubmed/12954777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12954777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.lowry.2006.6">Lowry JA, Mackay JP. GATA-1: one protein, many partners. <span><span class="ref-journal">Int J Biochem Cell Biol. </span>2006;<span class="ref-vol">38</span>:6–11.</span> [<a href="/pubmed/16095949" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16095949</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.mehaffey.2001.2681">Mehaffey MG, Newton AL, Gandhi MJ, Crossley M, Drachman JG. X-linked thrombocytopenia caused by a novel mutation of GATA-1. <span><span class="ref-journal">Blood. </span>2001;<span class="ref-vol">98</span>:2681–8.</span> [<a href="/pubmed/11675338" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11675338</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.muntean.2006.986">Muntean AG, Ge Y, Taub JW, Crispino JD. Transcription factor GATA-1 and Down syndrome leukemogenesis. <span><span class="ref-journal">Leuk Lymphoma. </span>2006;<span class="ref-vol">47</span>:986–97.</span> [<a href="/pubmed/16840187" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16840187</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.nichols.2000.266">Nichols KE, Crispino JD, Poncz M, White JG, Orkin SH, Maris JM, Weiss MJ. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">24</span>:266–70.</span> [<a href="/pubmed/10700180" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10700180</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.noris.2004.1219">Noris P, Pecci A, Di Bari F, Di Stazio MT, Di Pumpo M, Ceresa IF, Arezzi N, Ambaglio C, Savoia A, Balduini CL. Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. <span><span class="ref-journal">Haematologica. </span>2004;<span class="ref-vol">89</span>:1219–25.</span> [<a href="/pubmed/15477207" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15477207</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.nurden.2007.21">Nurden AT, Nurden P. The gray platelet syndrome: Clinical spectrum of the disease. <span><span class="ref-journal">Blood Rev. </span>2007;<span class="ref-vol">21</span>:21–36.</span> [<a href="/pubmed/16442192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16442192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.ohneda.2002.237">Ohneda K, Yamamoto M. Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage. <span><span class="ref-journal">Acta Haematol. </span>2002;<span class="ref-vol">108</span>:237–45.</span> [<a href="/pubmed/12432220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12432220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.parrella.2014.1319">Parrella S, Aspesi A, Quarello P, Garelli E, Pavesi E, Carando A, Nardi M, Ellis SR, Ramenghi U, Dianzani I. Loss of GATA-1 full length as a cause of Diamond-Blackfan anemia phenotype. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2014;<span class="ref-vol">61</span>:1319–21.</span> [<a href="/pmc/articles/PMC4684094/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4684094</span></a>] [<a href="/pubmed/24453067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24453067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.phillips.2007.2618">Phillips JD, Steensma DP, Pulsipher MA, Spangrude GJ, Kushner JP. Congenital erythropoietic porphyria due to a mutation in GATA1: the first trans-acting mutation causative for a human porphyria. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">109</span>:2618–21.</span> [<a href="/pmc/articles/PMC1852202/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1852202</span></a>] [<a href="/pubmed/17148589" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17148589</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.phillips.2005.515a">Phillips JD, Steensma DP, Spangrude GJ, Kushner JP. Congenital erythropoietic porphyria, beta-thalassemia intermedia and thrombocytopenia due to a GATA1 mutation. <span><span class="ref-journal">Blood. </span>2005;<span class="ref-vol">106</span>:515A.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.raskind.2000.2262">Raskind WH, Niakan KK, Wolff J, Matsushita M, Vaughan T, Stamatoyannopoulos G, Watanabe C, Rios J, Ochs HD. Mapping of a syndrome of X-linked thrombocytopenia with Thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia. <span><span class="ref-journal">Blood. </span>2000;<span class="ref-vol">95</span>:2262–8.</span> [<a href="/pubmed/10733494" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10733494</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.roberts.2013.3908">Roberts I, Alford K, Hall G, Juban G, Richmond H, Norton A, Vallance G, Perkins K, Marchi E, McGowan S, Roy A, Cowan G, Anthony M, Gupta A, Ho J, Uthaya S, Curley A, Rasiah SV, Watts T, Nicholl R, Bedford-Russell A, Blumberg R, Thomas A, Gibson B, Halsey C, Lee PW, Godambe S, Sweeney C, Bhatnagar N, Goriely A, Campbell P, Vyas P. GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">122</span>:3908–17.</span> [<a href="/pmc/articles/PMC3995281/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3995281</span></a>] [<a href="/pubmed/24021668" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24021668</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.roy.2009.3">Roy A, Roberts I, Norton A, Vyas P. Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. <span><span class="ref-journal">British Journal of Haematology. </span>2009;<span class="ref-vol">147</span>:3–12.</span> [<a href="/pubmed/19594743" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19594743</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.sankaran.2012.2439">Sankaran VG, Ghazvinian R, Do R, Thiru P, Vergilio JA, Beggs AH, Sieff CA, Orkin SH, Nathan DG, Lander ES, Gazda HT. Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. <span><span class="ref-journal">J Clin Invest. </span>2012;<span class="ref-vol">122</span>:2439–43.</span> [<a href="/pmc/articles/PMC3386831/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3386831</span></a>] [<a href="/pubmed/22706301" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22706301</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.singleton.2013.139">Singleton BK, Roxby DJ, Stirling JW, Spring FA, Wilson C, Poole J, Anstee DJ. A novel GATA1 mutation (Stop414Arg) in a family with the rare X-linked blood group Lu(a-b-) phenotype and mild macrothrombocytic thrombocytopenia. <span><span class="ref-journal">Br J Haematol. </span>2013;<span class="ref-vol">161</span>:139–42.</span> [<a href="/pubmed/23278136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23278136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.solis.2001.753">Solis C, Aizencang GI, Astrin KH, Bishop DF, Desnick RJ. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria. <span><span class="ref-journal">J Clin Invest. </span>2001;<span class="ref-vol">107</span>:753–62.</span> [<a href="/pmc/articles/PMC208941/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC208941</span></a>] [<a href="/pubmed/11254675" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11254675</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.thompson.1977.303">Thompson AR, Wood WG, Stamatoyannopoulos G. X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. <span><span class="ref-journal">Blood. </span>1977;<span class="ref-vol">50</span>:303–16.</span> [<a href="/pubmed/871527" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 871527</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.toki.2013.3181">Toki T, Kanezaki R, Kobayashi E, Kaneko H, Suzuki M, Wang R, Terui K, Kanegane H, Maeda M, Endo M, Mizuochi T, Adachi S, Hayashi Y, Yamamoto M, Shimizu R, Ito E. Naturally occurring oncogenic GATA1 mutants with internal deletions in transient abnormal myelopoiesis in Down syndrome. <span><span class="ref-journal">Blood. </span>2013;<span class="ref-vol">121</span>:3181–4.</span> [<a href="/pubmed/23440243" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23440243</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.tournamille.1995.224">Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">10</span>:224–8.</span> [<a href="/pubmed/7663520" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7663520</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.tsang.1997.109">Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, Weiss MJ, Crossley M, Orkin SH. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. <span><span class="ref-journal">Cell. </span>1997;<span class="ref-vol">90</span>:109–19.</span> [<a href="/pubmed/9230307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9230307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.tubman.2007.3297">Tubman VN, Levine JE, Campagna DR, Fleming MD, Neufeld EJ. X-linked gray platelet syndrome due to a GATA1 Arg261Gln mutation. <span><span class="ref-journal">Blood. </span>2007;<span class="ref-vol">109</span>:3297–9.</span> [<a href="/pubmed/17209061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17209061</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.waltzer.2003.6516">Waltzer L, Ferjoux G, Bataille L, Haenlin M. Cooperation between the GATA and RUNX factors Serpent and Lozenge during Drosophila hematopoiesis. <span><span class="ref-journal">EMBO J. </span>2003;<span class="ref-vol">22</span>:6516–25.</span> [<a href="/pmc/articles/PMC291817/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC291817</span></a>] [<a href="/pubmed/14657024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14657024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.wechsler.2002.148">Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD. Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome. <span><span class="ref-journal">Nat Genet. </span>2002;<span class="ref-vol">32</span>:148–52.</span> [<a href="/pubmed/12172547" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12172547</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.white.2007.620">White JG. Platelet pathology in carriers of the X-linked GATA-1 macrothrombocytopenia. <span><span class="ref-journal">Platelets. </span>2007;<span class="ref-vol">18</span>:620–7.</span> [<a href="/pubmed/18041654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18041654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.white.2007.436">White JG, Nichols WL, Steensma DP. Platelet pathology in sex-linked GATA-1 dyserythropoietic macrothrombocytopenia II. Cytochemistry. <span><span class="ref-journal">Platelets. </span>2007;<span class="ref-vol">18</span>:436–50.</span> [<a href="/pubmed/17763153" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17763153</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.yu.2002.2040">Yu C, Niakan KK, Matsushita M, Stamatoyannopoulos G, Orkin SH, Raskind WH. X-linked thrombocytopenia with thalassemia from a mutation in the amino finger of GATA-1 affecting DNA binding rather than FOG-1 interaction. <span><span class="ref-journal">Blood. </span>2002;<span class="ref-vol">100</span>:2040–5.</span> [<a href="/pmc/articles/PMC2808424/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2808424</span></a>] [<a href="/pubmed/12200364" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12200364</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="gata1.REF.zucker.2016.917">Zucker J, Temm C, Czader M, Nalepa G. A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation. <span><span class="ref-journal">Pediatr Blood Cancer. </span>2016;<span class="ref-vol">63</span>:917–21.</span> [<a href="/pmc/articles/PMC5138049/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5138049</span></a>] [<a href="/pubmed/26713410" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26713410</span></a>]</div></li></ul></div></div><div id="gata1.Chapter_Notes"><h2 id="_gata1_Chapter_Notes_">Chapter Notes</h2><div id="gata1.Author_History"><h3>Author History</h3><p>Stella T Chou, MD (2006-present)<br />Melissa A Kacena, PhD (2006-present)<br />Jessica Kirk, BS; Yale University School of Medicine (2006-2011)<br />Wendy H Raskind, MD, PhD (2006-present)<br />Mitchell J Weiss, MD, PhD (2006-present)</p></div><div id="gata1.Acknowledgments"><h3>Acknowledgments</h3><p>This work was supported in part by NIH grants NCRR RR025760 and RR025761 (MAK), NIH K08 HL093290 and R01 DK100854 (STC), NIH P30 DK090969 (MJW, STC), P30 DK0724429 (MAK), NIAMS R03 AR055269 (MAK), NIAMS R01 AR060332 (MAK), NIA R01 AG046246 (MAK) and by the American Society of Hematology Scholar Award (STC).</p></div><div id="gata1.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>11 May 2017 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>17 April 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 March 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 March 2007 (cd) Revision: prenatal testing clinically available</div></li><li class="half_rhythm"><div>21 February 2007 (cd) Revision: clinical testing available</div></li><li class="half_rhythm"><div>22 November 2006 (me) Review posted live</div></li><li class="half_rhythm"><div>10 August 2006 (whr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1364</span><span class="label">PMID: <a href="/pubmed/20301538" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301538</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/cmt2d/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/cmt-4a/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1364&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1364/?report=reader">PubReader</a></li><li><a href="/books/NBK1364/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1364" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1364" style="display:none" title="Cite this Page"><div class="bk_tt">Chou ST, Kacena MA, Weiss MJ, et al. GATA1-Related X-Linked Cytopenia. 2006 Nov 22 [Updated 2017 May 11]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1364/pdf/Bookshelf_NBK1364.pdf">PDF version of this page</a> (498K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#gata1.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#gata1.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#gata1.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#gata1.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#gata1.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#gata1.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#gata1.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#gata1.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#gata1.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#gata1.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#gata1.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2623[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">GATA1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1460754" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1460754" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1460754" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1460754" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301769" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Diamond-Blackfan Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Clinton C, Gazda HT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24027798" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Erythropoietic Porphyria</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Congenital Erythropoietic Porphyria<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Erwin A, Balwani M, Desnick RJ, Porphyrias Consortium of the NIH-Sponsored Rare Diseases Clinical Research Network. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301357" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAS</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">WAS</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chandra S, Bronicki L, Nagaraj CB, Zhang K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301575" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Fanconi Anemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mehta PA, Tolar J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301599" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Thalassemia</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Beta-Thalassemia<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Origa R. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301538" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301538" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e04132cdde0891169ba3499">GATA1-Related X-Linked Cytopenia - GeneReviews®</a><div class="ralinkpop offscreen_noflow">GATA1-Related X-Linked Cytopenia - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:55:56-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CDE4FE0402651000000000711026C&amp;ncbi_session=CE8CDE4FE04132B1_1809SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1364%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1364&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1364/&amp;ncbi_pagename=GATA1-Related X-Linked Cytopenia - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CDE4FE04132B1_1809SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>